Ikena Oncology: Soars in Nasdaq debut

ImageneBio

26/03/2021 20:00

** Shares of Ikena Oncology Inc  IKNA.O  soar more than 94%
to $31 after their stock market debut
    ** IKNA's shares opened at $22.40, nearly 40% above their
IPO price of $16 per share
    ** Shares were halted multiple times during the day for
volatility
    ** Co offered about 7.8 mln shares in IPO, raising about
$125 mln
    ** IKNA is a targeted oncology company focused on developing
cancer therapies
    ** Jefferies, Cowen, Credit Suisse and William Blair were
the joint book-running managers for the offering

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))